Cancer Biology advertising materials, including posters, brochures, pamphlets, and services, will be seamlessly integrated with information and distributed to hospitals, universities, societies, and researchers Young Scientist Benefits Our conferences provide best Platform for your research through oral presenta...
In collaboration with top-tier hospitals and universities in the region, they have launched a project called “Retrospective analysis of breast cancer diagnosis among young and older women in the UAE.” These retrospective studies will establish a benchmark to assess the accuracy of diagnosis and ...
Innovators in Cancer Stem Cell Research Translational Researchers bridging lab work and clinical applications Hospitals and Cancer Centers Multispecialty and Cancer-Specialized Hospitals Comprehensive Cancer Research and Treatment Centers Palliative Care Units Pharmaceutical and Biotech Industry Professionals Oncology...
PARP inhibitors (PARPi) have shown efficacy in tumours harbouring mutations in homologous recombination repair (HRR) genes. Somatic HRR mutations have been described in patients with Non-Small Cell Lung Cancer (NSCLC), but PARP inhibitors (PARPi) are not yet a therapeutic option. Here we assess...
ROS delivers accessible, quality medical equipment solutions. Check out our inventory of refurbished & used radiation therapy & diagnostic imaging equipment.
“We have selected strong partners with deep experience and relationships in the urology and pediatric setting who will help us serve the product and education needs of physicians and hospitals. Palette and its network of partners are making significant investments within local markets to ...
Our goal is to become a reliable healthcare partner for hospitals and clinics. We strive to meet the rigorous standards set by the American College of Radiology. Our commitment to excellence 2 is unwavering. Our tailored medical physics care services ensure accuracy and consistency in supporting yo...
including variability in imaging protocols among different hospitals, heterogeneity in patient populations, preprocessing (image normalization, noise reduction, and image segmentation), feature selection, and model training111. Developing multicenter studies assessing the standardization of protocols and workflows...
Based on AI algorithms, it is possible to determine how often a patient should be screened for breast cancer to avoid its development in the next 5 years. One of the AI models used in breast cancer oncology is Mirai [32]. This model was validated in seven hospitals across five countries ...
Hospital volume can also significantly influence outcomes for genitourinary malignancies, with high-volume hospitals offering lower rates of perioperative morbidity and mortality [71,72,73]. However, access to these hospitals is unevenly distributed, with Black patients and those of lower socioeconomic st...